《半日總結》恆指升119點 藥明生物反彈 太古急漲
港股早市反彈,恆指低開15點,初段曾跌93點見16,234點,其後曾倒升140點見16,468點。半日升119點或0.73%,報16,447點;國指升40點或0.7%,報5,649點;恆生科技指數升47點或1.3%,報3,730點。大市半日成交總額482.26億元,滬、深港通南下交易淨流入17億及6.91億元人民幣。
藥明生物(02269.HK)擬斥不逾6億美元回購,股價反彈5.3%,同系藥明康德(02359.HK)升3.3%。金沙中國(01928.HK)控股股東擬資斥最多19.5億元增持股份,股價升4.2%。太古擬未來兩年回購最多60億元股份,太古A(00019.HK)升15.4%。比亞迪(01211.HK)董事長王傳福計劃購買不超過人民幣2億元公司A股股份,股價升3.6%。
科技股方面,阿里(09988.HK)跌0.9%報69.85元。騰訊(00700.HK)、小米(01810.HK)及京東(09618.HK)升0.4%至0.7%,美團(03690.HK)及快手(01024.HK)升1.9%及1.1%,百度(09888.HK)、網易(09999.HK)及嗶哩嗶哩(09626.HK)升2.9%至3.7%。此外,美圖(01357.HK)及聯想集團(00992.HK)各反彈7.8%。金蝶(00268.HK)及閱文(00772.HK)升逾3%。
消費內需股方面,李寧(02331.HK)、滔搏(06110.HK)、特步(01368.HK)、維他奶(00345.HK)、海底撈(06862.HK)及同程旅行(00780.HK)升3.1%至4.2%。歐舒丹(00973.HK)跌3.3%失守20元。電動車股蔚來(09866.HK)料獨立造車能減少一成成本,股價升4.3%。鋰材料股贛鋒鋰業(01772.HK)及天齊鋰業(09696.HK)升6.6%及8.4%。
金融股方面,匯控(00005.HK)升1%報59.8元,港交所(00388.HK)升0.4%,友邦(01299.HK)跌0.2%。招行(03968.HK)及交行(03328.HK)升逾2%。本地地產股恆地(00012.HK)升3.6%,新世界(00017.HK)、恆隆地產(00101.HK)、太古地產(01972.HK)及九倉置業(01997.HK)升2.3%至2.7%。
內房股恆大(03333.HK)已收到法院就恆大物業(06666.HK)提出訴訟通知,恆大跌3.5%,恆大物業升2.2%。微創醫療(00853.HK)擬發2.2億美元2028年到期5.75%可換股債及計劃購回7億美元2026年到期零息可換股債券,股價挫18%,半日成交逾4.9億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.